Medicare Enrolled
Dr. Akira Yamamoto, MD
Urology Physician · Lawrenceville, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Yamamoto from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yamamoto?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yamamoto
Dr. Akira Yamamoto is an urology physician in Lawrenceville, NJ, with 15 years of NPI registration. Based on federal Medicare data, Dr. Yamamoto performed 3,765 Medicare services across 2,542 unique beneficiaries.
Between the years covered by Open Payments, Dr. Yamamoto received a total of $3,470 from 33 pharmaceutical and/or device companies across 178 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yamamoto is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 42% volume in NJ
$3,470 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,765
Medicare services
Top 42% in NJ for urology physician
2,542
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~251 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
856 | $97 | $274 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
813 | $2 | $10 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
734 | $8 | $115 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
265 | $64 | $188 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
168 | $65 | $175 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
137 | $140 | $495 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 121 | $131 | $688 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
108 | $127 | $412 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
107 | $196 | $890 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
73 | $20 | $58 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
54 | $11 | $72 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
41 | $116 | $2,419 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
37 | $91 | $274 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
36 | $42 | $201 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
34 | $351 | $2,241 |
| Endoscopic removal of urethral or bladder foreign body A procedure to remove a stone, stent, or other object from the urethra or bladder using an endoscope. The endoscope allows the provider to visualize and extract the item through the urinary tract. |
24 | $381 | $2,095 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
23 | $27 | $121 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
20 | $93 | $369 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
18 | $38 | $78 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
17 | $117 | $340 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
15 | $49 | $425 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
14 | $84 | $389 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
13 | $550 | $3,699 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
13 | $199 | $1,443 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
13 | $101 | $276 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
11 | $43 | $116 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.0% high complexity
26.1% medium
71.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,470
Total received (2018-2024)
Avg $496/year across 7 years
Top 37% in NJ for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
178
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,313 (95.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$157 (4.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$73
2023
$218
2022
$166
2021
$1,211
2020
$429
2019
$858
2018
$515
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Myriad Genetic Laboratories, Inc.
$73
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$566
Myriad Genetic Laboratories, Inc.
$446
Endo Pharmaceuticals Inc.
$347
Janssen Biotech, Inc.
$257
NeoTract Inc.
$182
Antares Pharma, Inc.
$176
Dendreon Pharmaceuticals LLC
$174
TOLMAR Pharmaceuticals, Inc.
$133
PROCEPT BioRobotics Corporation
$125
Aytu BioScience, Inc
$118
Myovant Sciences Inc.
$93
Bayer HealthCare Pharmaceuticals Inc.
$91
Medtronic, Inc.
$76
BOSTON SCIENTIFIC CORPORATION
$65
Boston Scientific Corporation
$60
Clarus Therapeutics Inc.
$56
Ferring Pharmaceuticals Inc.
$54
AbbVie, Inc.
$54
Alnylam Pharmaceuticals Inc.
$49
Mission Pharmacal Company
$47
Amgen Inc.
$43
UROVANT SCIENCES INC
$37
Blue Earth Diagnostics Limited
$37
Metuchen Pharmaceuticals
$30
PFIZER INC.
$27
Acerus Pharmaceuticals Corporation
$24
Allergan, Inc.
$17
DENTSPLY IH Inc.
$17
COLOPLAST CORP
$17
ROCHESTER MEDICAL CORPORATION
$16
AbbVie Inc.
$14
NxThera, Inc.
$12
Avadel Specialty Pharmaceuticals, LLC
$12
Top 3 companies account for 39.2% of all-time payments
Associated products mentioned in payments ›
AMS · AMS 700 CXR RTE KIT · AQUABEAM ROBOTIC SYSTEM · Androgel · Axumin · BOTOX · BRACANALYSIS CDX · CLENPIQ · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL UTERINE TISSUE REMOVAL · GREENLIGHT · INTERSTIM · JATENZO · LITHOVUE · LUPRON DEPOT · LoFric · Lupron · Lupron Depot · MYRBETRIQ · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · OXLUMO · Otrexup · PROLARIS · PROVENGE · Prolaris · Prolia · REZUM · Rezum · Stendra · TOVIAZ · Titan · Uribel · UroLift · VESICARE · XIAFLEX · XTANDI · XYOSTED · Xofigo · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
145
Per 100K population
37.8
County median income
$96,333
Nearest hospital
CAPITAL HEALTH REGIONAL MEDICAL CENTER
3.2 mi
3.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Yamamoto is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Yamamoto experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Yamamoto performed 856 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yamamoto receive payments from pharmaceutical companies?
Yes. Dr. Yamamoto received a total of $3,470 from 33 companies across 178 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yamamoto's costs compare to other urology physicians in Lawrenceville?
Dr. Yamamoto's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yamamoto) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Lawrenceville
Browse urology physicians in Lawrenceville ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NJ
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NJ
Which NJ urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Myriad Genetic Laboratories, Inc. Payments to Doctors
See all physicians who received payments from Myriad Genetic Laboratories, Inc.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology